COMP <GO>
CCK vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Crown Holdings Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CCK 8
— TMO 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CCK
LAST: $118.20 (+1.68%) • MKT CAP: $12.77B
roic
16.10%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCK VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CCK | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 16.10% | 9.30% | +6.80 | CCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.1x | 30.4x | -21.30 | CCK | /valuation <GO> |
| Free Cash Flow Yield | 8.75% | 2.40% | +6.35 | CCK | /fcf-yield <GO> |
| Operating Margin | 12.60% | 17.40% | -4.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 15.10% | -9.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 4.80% | 3.90% | +0.90 | CCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.94% | 0.24% | +0.70 | CCK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.73 | 4.50 | -1.77 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 62.9 | +0.70 | CCK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.94 | +0.11 | CCK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.1x | 36.3x | -20.20 | CCK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.77B | $262.22B | -$249.45B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CCK REV | TMO REV | CCK GROSS % | TMO GROSS % | CCK FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.37B | $44.56B | — | — | $1.12B | $6.29B |
| FY 2024 | $11.80B | $42.88B | — | — | $789.0M | $7.27B |
| FY 2023 | $12.01B | $42.86B | — | — | $912.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCK // BETA 1.05
TMO // BETA 0.94